Results for “FFAG”

DOE OSTI2019

Simulation of the CBETA 4-pass FFAG ERL using field maps — exclusively

The Cornell-BNL Electron Test Accelerator (CBETA), a four-pass, 150 MeV energy recovery linac (ERL), is now in construction at Cornell. Commissioning commenced on March 2019. A particularity of CBETA is that a single channel loop recirculates the four energies (42, 78, 114 and 150 MeV). The return loop arcs are based on fixed-field alternating gradient (FFAG) optics. The loop is comprised of 107 quadrupole-doublet cells, built using Halbach permanent magnet technology. Spreader and combiner sections (4 independent beam lines each) connect the 36 MeV linac to the FFAG arcs. We introduce here a start-to-end simulation of the 4-pass ERL, based entirely, and exclusively, on the use of magnetic field maps to model the optical components.

43 PARTICLE ACCELERATORS↗

DOE OSTI2020

Compact, Achromatic Non-scaling FFAG Accelerator for HEP, Commercial and Medical Applications (CRADA FRA-2008-0005 Final Report)

Proton and light-ion accelerators have many research and medical applications, but the current state of technology in accelerators severely limits their widespread use: (1) synchrotrons have an intrinsic low duty cycle and become quite large for light ions; and (2) cyclotrons do not have energy variability and require complex superconducting magnets for high energy. A new concept in non-scaling Fixed-Field Alternating-Gradient (FFAGs) has been invented that incorporates both the energy variability of the synchrotron and the high duty cycle of the cyclotron. The concept uses normal-conducting, combined-function magnets that apply only constant (dipole) and linear-gradient (quadrupole) fields to stabilize the accelerator. This project will develop an optimized design for a new non-scaling and cost-effective innovation in FFAG accelerators. The accelerator design will have optics that can stably accelerate protons to 250 MeV (or higher) and carbon ions to =200 MeV, an energy considered ideal for radiation therapy. Phase I will optimize, fully simulate, and demonstrate the feasibility of this accelerator. Commercial Applications and other Benefits as described by the awardee: The fixed-field acceleration concept should eliminate some of the most pronounced technical difficulties, expense, maintenance, and required expertise faced in conventional proton and light-ion accelerators. In addition to the application for high energy physics, these accelerators should have application in cancer treatment, radiopharmaceuticals, and medical isotope production, and materials science.

43 PARTICLE ACCELERATORS↗